Omu Anzala

International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations

Dan H. Barouch, Sandra V. Kik, Gerrit Jan Weverling et al. · Vaccine · 2011 · 302 citations

Diagnostic Virology, Viral Diagnostics, International Seroepidemiology +5

Identifying At-Risk Populations in Kenya and South Africa

Matt A. Price, Wasima Rida, Mary Mwangome et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2012 · 113 citations

Safety and Immunogenicity of a 2-Dose Heterologous Vaccine Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Nairobi, Kenya

Gaudensia Mutua, Omu Anzala, Kerstin Lühn et al. · The Journal of Infectious Diseases · 2019 · 94 citations · Full text

Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility

Vineet Joag, Onyango Obila, Pawel Gajer et al. · Clinical Infectious Diseases · 2018 · 87 citations · Full text

Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa

Houreratou Barry, Gaudensia Mutua, Hannah Kibuuka et al. · PLoS Medicine · 2021 · 65 citations · Full text